Financing, Equity Capital Markets

Kymera Therapeutics LLC

07/21
|
$257.0 Million
Piper Sandler served as bookrunner for Kymera Therapeutics LLC on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma